Popular diabetes and weight-loss drug may reduce risk of Alzheimer's disease
Science Daily: Pharmacology News
OCTOBER 24, 2024
Researchers have found that semaglutide may lower the risk of Alzheimer's disease in people with type 2 diabetes (T2D).
Thu.Oct 24, 2024
325 
Intellia data spark debate about CRISPR drug’s potential
BioPharma Drive: Drug Pricing
OCTOBER 24, 2024
Newly published data show the therapy reduced the rate of swelling attacks in people with hereditary angioedema, but didn't silence questions about its commercial outlook.
Join 15,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Unnoticeable electric currents could reduce skin infections
Science Daily: Pharmacology News
OCTOBER 24, 2024
Using a few zaps of electricity to the skin, researchers can stop bacterial infections without using any drugs. For the first time, researchers designed a skin patch that uses imperceptible electric currents to control microbes.
Ozempic, Wegovy Might Help Lower Alzheimer's Risk in People With Diabetes
Drugs.com
OCTOBER 24, 2024
THURSDAY, Oct. 24, 2024 -- Add Alzheimer’s disease to the list of conditions that might benefit from the revolutionary diabetes drug Ozempic, a new study says.People with type 2 diabetes taking semaglutide appeared to have a significantly lower r.
Bridging Innovation & Patient Care: The Growing Role of AI
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Scientists develop grain-sized soft robots controlled by magnetic fields for targeted drug delivery
Science Daily: Pharmacology News
OCTOBER 24, 2024
A team of scientists has developed grain-sized soft robots that can be controlled using magnetic fields for targeted drug delivery, paving the way to possible improved therapies in future.
Signup to get articles personalized to your interests!
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
More Trending
Gut bacteria transfer genes to disable weapons of their competitors
Science Daily: Pharmacology News
OCTOBER 24, 2024
New research shows that a large, ubiquitous mobile genetic element changes the antagonistic weaponry of Bacteroides fragilis, a common bacterium of the human gut.
CDC Lowers Age for First Pneumococcal Vaccine to 50
Drugs.com
OCTOBER 24, 2024
THURSDAY, Oct. 24, 2024 -- The recommended first age at which Americans should get the pneumococcal vaccine has been lowered from 65 to 50, the U.S. Centers for Disease Control and Prevention announced Wednesday."Lowering the age for pneumococcal.
Successful experiment paves the way for new element
Science Daily: Pharmacology News
OCTOBER 24, 2024
Scientists have found an alternative way to produce atoms of the superheavy element livermorium. The new method opens up the possibility of creating another element that could be the heaviest in the world so far: number 120.
More Kids With Food Allergies Are Needing Psychological Care
Drugs.com
OCTOBER 24, 2024
THURSDAY, Oct. 24, 2024 -- Anxiety is driving more children with potentially dangerous food allergies to seek out psychological care, a new study finds.Focusing on one Ohio hospital, the researchers found a more than 50% jump in psychology.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Chronic pain can be predicted within three days of an injury
Science Daily: Pharmacology News
OCTOBER 24, 2024
After only one to three days of a whiplash injury, scientists can predict which patients will develop chronic pain based on the extent of cross 'talk' between two regions of the brain, and the person's anxiety level after the injury, according to a new study. The study showed the more the hippocampus -- the brain's memory center -- talked to the cortex -- involved in long term memory storage -- the more likely the person is to develop chronic pain.
Private Balcony Hot Tubs Spread Legionnaires Disease on Cruise Ships
Drugs.com
OCTOBER 24, 2024
THURSDAY, Oct. 24, 2024 -- Next time you're on a cruise, be wary of your (or your neighbor's) private balcony hot tub, researchers warn.These luxe cabin features were pinpointed as a source of outbreaks of the respiratory illness Legionnaires.
Human actions likely cause insect color change
Science Daily: Pharmacology News
OCTOBER 24, 2024
New Zealand's native stoneflies have changed colour in response to human-driven environmental changes, new research shows. The study provides arguably the world's most clear-cut case of animal evolution in response to change made by humans.
Onions in McDonalds' Quarter Pounders Linked to E. Coli Outbreak Have Been Recalled
Drugs.com
OCTOBER 24, 2024
THURSDAY, Oct. 24, 2024 -- Just days after an E. coli outbreak tied to McDonald's Quarter Pounders was first announced, a company producing onions used in the burgers said it has issued a recall for its diced, peeled and whole onions. The onions.
How Machine Learning Drives Clinical Trial Efficiency
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Millions in the U.S. may rely on groundwater contaminated with PFAS for drinking water supplies
Science Daily: Pharmacology News
OCTOBER 24, 2024
Approximately 71 to 95 million people in the Lower 48 states -- more than 20% of the country's population -- may rely on groundwater that contains detectable concentrations of per- and polyfluoroalkyl substances, also known as PFAS, for their drinking water supplies.
Lyell, in search of a turnaround, to buy cell therapy startup ImmPact
BioPharma Drive: Drug Pricing
OCTOBER 24, 2024
The deal will give Lyell a dual-targeting CAR-T candidate for blood cancers. Relatedly, Lyell has opted to end development of two current pipeline programs.
Key to low-cost, long-lasting renewable batteries for electric vehicles
Science Daily: Pharmacology News
OCTOBER 24, 2024
Lithium-sulfur batteries have never lived up to their potential as the next generation of renewable batteries for electric vehicles and other devices. But mechanical engineers have now found a way to make these Li-S batteries last longer -- with higher energy levels -- than existing renewable batteries.
GPCR drugmaker Septerna amasses $288M in IPO
BioPharma Drive: Drug Pricing
OCTOBER 24, 2024
Septerna is the 23rd biotech to go public this year, raising funds to advance its lead candidate, a treatment for hypoparathyroidism now in Phase 1 testing.
Deliver Fast, Flexible Clinical Trial Insights with Spotfire
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
A new hydrogel semiconductor represents a breakthrough for tissue-interfaced bioelectronics
Science Daily: Pharmacology News
OCTOBER 24, 2024
The ideal material for interfacing electronics with living tissue is soft, stretchable, and just as water-loving as the tissue itself--in short, a hydrogel. Semiconductors, the key materials for bioelectronics such as pacemakers, biosensors, and drug delivery devices, on the other hand, are rigid, brittle, and water-hating, impossible to dissolve in the way hydrogels have traditionally been built.
Naloxone Implant Might Prevent Opioid Overdose
Drugs.com
OCTOBER 24, 2024
THURSDAY, Oct. 24, 2024 -- Naloxone can save a person’s life by reversing a potentially fatal opioid overdose, and is now available as an over-the-counter medication. Unfortunately, there’s a very significant catch. A knowledgeable.
Fire-risk blocking self-powered hydrogen production system
Science Daily: Pharmacology News
OCTOBER 24, 2024
By using a water-splitting system with an aqueous electrolyte, this system is expected to block fire risks and enable stable hydrogen production.
Greater Access to New Weight Loss Meds Could Save More Than 40,000 Lives Per Year
Drugs.com
OCTOBER 24, 2024
THURSDAY, Oct. 24, 2024 -- Expanding access to cutting-edge diabetes and weight-loss drugs like Ozempic and Zepbound could prevent more than 42,000 deaths a year in the United States, a new study claims.Obesity and all its attendant ills -- type 2.
Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Beneficial gut microbe has surprising metabolic capabilities
Science Daily: Pharmacology News
OCTOBER 24, 2024
Researchers discovered potentially far-reaching effects of a particular gut bacterium that was linked to better growth in Bangladeshi children receiving a therapeutic food designed to nurture healthy gut microbes. A strain of the bacterium harbored in the children's gut microbial communities possessed a previously unknown gene capable of producing and metabolizing key molecules involved in regulating many important functions ranging from appetite, immune responses, neuronal function, and the abi
J&J’s Asish Xavier on biotech’s rebound in a volatile era
BioPharma Drive: Drug Pricing
OCTOBER 24, 2024
Xavier, who leads biotech venture investing for the big drugmaker, expects an uptick in IPOs as well as renewed interest in the newer crop of gene and cell therapy companies.
Wildfires are becoming faster and more dangerous in Western U.S.
Science Daily: Pharmacology News
OCTOBER 24, 2024
Fire speed, not size, drives threat to people and infrastructure.
Merck, Pfizer lifted as CDC backs broader use of pneumococcal vaccines
BioPharma Drive: Drug Pricing
OCTOBER 24, 2024
An agency panel recommended lowering the age for routine vaccination from 65 to 50, boosting the revenue outlook for multiple shots on the market and in development.
Dandelion-shaped supernova and zombie star
Science Daily: Pharmacology News
OCTOBER 24, 2024
A historical supernova documented by Chinese and Japanese astronomers in 1181 has been lost for centuries, until very recently. Yet, the newly found remnant shows some stunning characteristics that are puzzling astronomers. Now, it surrenders its secrets. A team provides the first detailed study of the supernova's structure and speed of expansion in 3D.
Let's personalize your content